Unlicensed and off label drug use in neonates
- PMID: 10325794
- PMCID: PMC1720896
- DOI: 10.1136/fn.80.2.f142
Unlicensed and off label drug use in neonates
Abstract
Aim: To determine the extent of use of drugs that are either not licensed (unlicensed), or are outside the terms of their product licence (off label) in a neonatal intensive care unit.
Methods: A prospective study was conducted over 13 weeks.
Results: 455 prescription episodes were administered to 70 babies. 63 (90%) patients were given a drug that was either unlicensed or used in an off label way. 54.7% prescription episodes were off label, many for more than one reason, and 9.9% (45) were unlicensed; 35.4% (161) prescription episodes were licensed.
Conclusion: The use of unlicensed and off label drugs in neonatal intensive care seems to be far greater than other paediatric settings. This highlights the difficulties faced by those trying to ensure safe and effective prescribing for neonates. Urgent action is required to resolve this situation.
Comment in
-
Unlicensed and off label drug use in neonates.Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F77-8. doi: 10.1136/fn.82.1.f77a. Arch Dis Child Fetal Neonatal Ed. 2000. PMID: 10702000 Free PMC article. No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources